Related references
Note: Only part of the references are listed.Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance
Giorgia Acquaviva et al.
HISTOPATHOLOGY (2018)
Anaplastic thyroid carcinoma: review of treatment protocols
Vera Tiedje et al.
ENDOCRINE-RELATED CANCER (2018)
Canonical signaling and nuclear activity of mTORa teamwork effort to regulate metabolism and cell growth
Vincent Giguere
FEBS JOURNAL (2018)
The Target of Rapamycin and Mechanisms of Cell Growth
Andrew R. Tee
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
Yazhuo Zhang et al.
MOLECULAR CANCER (2018)
Long-acting insulin analogs and cancer
L. Sciacca et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2018)
A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer
Antonino Belfiore et al.
CELL ADHESION & MIGRATION (2018)
Editorial: Clinical and Molecular Epidemiology of Thyroid Cancer of Follicular Origin
Roberta Malaguarnera et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2017)
Spectrum of lesions derived from branchial arches occurring in the thyroid: from solid cell nests to tumors
Kristyna Srbecka et al.
VIRCHOWS ARCHIV (2017)
The thyroid cancer epidemic, 2017 perspective
Benjamin R. Roman et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2017)
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells
Veronica Vella et al.
ONCOTARGET (2017)
Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets
Domenico Ciavardelli et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics
Martina Tavarelli et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?
Roberta Malaguarnera et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
Veronica Vella et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Hepatocyte growth factor/MET in cancer progression and biomarker discovery
Kunio Matsumoto et al.
CANCER SCIENCE (2017)
Solid cell nests of the thyroid gland: morphological, immunohistochemical and genetic features
Marco Manzoni et al.
HISTOPATHOLOGY (2016)
Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study
Cuneyd Anil et al.
MEDICAL PRINCIPLES AND PRACTICE (2016)
PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas
Zahra Nozhat et al.
MOLECULAR DIAGNOSIS & THERAPY (2016)
Normal vs cancer thyroid stem cells: the road to transformation
M. Zane et al.
ONCOGENE (2016)
IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway
Roberta Mata et al.
ONCOTARGET (2016)
Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer
Sujata Narayanan et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Tyrosine-kinase inhibitors to treat radioiodine-refracted, metastatic, or recurred and progressive differentiated thyroid carcinoma [Review]
Yasuhiro Ito et al.
ENDOCRINE JOURNAL (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
Discoidin Domain Receptors: Potential Actors and Targets in Cancer
Hassan Rammal et al.
FRONTIERS IN PHARMACOLOGY (2016)
Cancer Stem Cells in the Thyroid
Yuji Nagayama et al.
FRONTIERS IN ENDOCRINOLOGY (2016)
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features
Fiorenza Giani et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses
Roberta Malaguarnera et al.
ONCOTARGET (2015)
Novel aspects concerning the functional cross-talk between the insulin/IGF-I system and estrogen signaling in cancer cells
Paola De Marco et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Biological Effects of Insulin and Its Analogs on Cancer Cells With Different Insulin Family Receptor Expression
Laura Sciacca et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Switch in Signaling Control of mTORC1 Activity After Oncoprotein Expression in Thyroid Cancer Cell Lines
Roberta Malaguarnera et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
Guoping He et al.
ONCOLOGY LETTERS (2014)
Type 3 deiodinase: role in cancer growth, sternness, and metabolism
Domenico Ciavardelli et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Stem cell biology in thyroid cancer: Insights for novel therapies
Parisha Bhatia
World Journal of Stem Cells (2014)
The Pathogenetic Role of the HGF/c-Met System in Papillary Carcinoma of the Thyroid
Luigi Ruco et al.
BIOMEDICINES (2014)
被撤回的出版物: Thyroid Cancer Cell Resistance to gefitinib Depends on the Constitutive Oncogenic Activation of the ERK Pathway (Retracted article. See FEB, 2023)
Francesco Frasca et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Alan L. Ho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The changing face of thyroid cancer in a population-based cohort
K. Alok Pathak et al.
CANCER MEDICINE (2013)
Expression and significance of IGF-1 and IGF-1R in thyroid nodules
Ying-Jian Liu et al.
ENDOCRINE (2013)
Insulin receptor isoforms are differently expressed during human osteoblastogenesis
Sofia Avnet et al.
DIFFERENTIATION (2012)
Insulin and Insulin-like Growth Factor II Differentially Regulate Endocytic Sorting and Stability of Insulin Receptor Isoform A
Alaide Morcavallo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Metformin Inhibits Growth of Thyroid Carcinoma Cells, Suppresses Self-Renewal of Derived Cancer Stem Cells, and Potentiates the Effect of Chemotherapeutic Agents
Guofang Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Insulin Analogs and Cancer
Laura Sciacca et al.
Frontiers in Endocrinology (2012)
The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis
Roberta Malaguarnera et al.
JOURNAL OF ONCOLOGY (2012)
Insulin receptor and cancer
Antonino Belfiore et al.
ENDOCRINE-RELATED CANCER (2011)
Insulin Receptor Isoforms and Insulin-Like Growth Factor Receptor in Human Follicular Cell Precursors from Papillary Thyroid Cancer and Normal Thyroid
Roberta Malaguarnera et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
Debyani Chakravarty et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism
Arlee Fafalios et al.
NATURE MEDICINE (2011)
Molecular genetics and diagnosis of thyroid cancer
Yuri E. Nikiforov et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Metformin Treatment for Small Benign Thyroid Nodules in Patients with Insulin Resistance
Jorge Rezzonico et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2011)
Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice
Aime T. Franco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Insulin Receptor: A New Target for Cancer Therapy
Roberta Malaguarnera et al.
Frontiers in Endocrinology (2011)
Tumorigenic and Metastatic Activity of Human Thyroid Cancer Stem Cells
Matilde Todaro et al.
CANCER RESEARCH (2010)
Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA, and AKT1
Julio C. Ricarte-Filho et al.
CANCER RESEARCH (2009)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role
E. Fiore et al.
ENDOCRINE-RELATED CANCER (2009)
Delta NP73 alpha inhibits PTEN expression in thyroid cancer cells
Veronica Vella et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage
Megan Rist Haymart et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Thyroid carcinoma: molecular pathways and therapeutic targets
Yuri E. Nikiforov
MODERN PATHOLOGY (2008)
Cyclic AMP Inhibits the Proliferation of Thyroid Carcinoma Cell Lines through Regulation of CDK4 Phosphorylation
Ana Sofia Rocha et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation
Roberta Malaguarnera et al.
MOLECULAR CANCER RESEARCH (2008)
Thyroid-stimulating hormone-initiated proliferative signals converge in vivo on the mTOR kinase without activating AKT
Charlene Brewer et al.
CANCER RESEARCH (2007)
TSH signalling and cancer
Custodia Garcia-Jimenez et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2007)
p53 family proteins in thyroid cancer
R. Malaguarnera et al.
ENDOCRINE-RELATED CANCER (2007)
Pathology and genetics of thyroid carcinoma
Ronald A. Delellis
JOURNAL OF SURGICAL ONCOLOGY (2006)
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
T Kondo et al.
NATURE REVIEWS CANCER (2006)
The p53-homologue p63 may promote thyroid cancer progression
R Malaguarnera et al.
ENDOCRINE-RELATED CANCER (2005)
Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer:: Biological effects of HGF in thyroid cancer cells depend on Met expression levels
R Mineo et al.
ENDOCRINOLOGY (2004)
Minireview: Thyrotropin receptor signaling in development and differentiation of the thyroid gland: Insights from mouse models and human diseases
M De Felice et al.
ENDOCRINOLOGY (2004)
Thyrotropin (TSH)-Induced production of vascular endothelial growth factor in thyroid cancer cells in vitro:: Evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors
S Hoffmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Exclusion of c-Abl from the nucleus restrains the p73 tumor suppression function
V Vella et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved
G Pandini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The IGF system in thyroid cancer: new concepts
V Vella et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic β cells
B Leibiger et al.
MOLECULAR CELL (2001)
Expression of the PTEN tumour suppressor protein during human development
O Gimm et al.
HUMAN MOLECULAR GENETICS (2000)
Role of insulin and serum on thyrotropin regulation of thyroid transcription factor-1 and Pax-8 genes expression in FRTL-5 thyroid cells
DL Medina et al.
THYROID (2000)
Share Paper
